8th Dec 2020 16:10
(Alliance News) - Oxford University and AstraZeneca PLC became the first Covid-19 vaccine makers to publish final-stage clinical trial results in a scientific journal Tuesday, clearing a key hurdle in the global race to develop safe and effective drugs for the new coronavirus.  Â
The study published in the respected Lancet medical journal confirmed that the vaccine works in an average 70% of cases, with efficacy of 62% for those given two full doses, and of 90% in those given a half then a full dose.Â
The results are the "first full peer-reviewed efficacy results" published for a Covid-19 vaccine, the Lancet said.
Shares in AstraZeneca were up 0.5% at 8,114.00 pence on Tuesday afternoon in London.
source: AFP
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Astrazeneca